TNZTP TAPDİ OKSİJEN ÖZEL SAĞLIK VE EĞİTİM HİZMETLERİ SANAYİ TİCARET A.Ş. Stock
Tapdi Oksijen Özel Sağlık ve Eğitim Hizmetleri Sanayi Ticaret A.Ş., sağlık hizmetleri ve eğitim alanında faaliyet göstermektedir. Özel sağlık hizmetleri sunarak sektördeki ihtiyaçları karşılamaktadır.
| Period | Revenue | EBITDA | Net Income |
|---|---|---|---|
| 2026 Q1 | 969.3M | 254.6M | 72.8M |
| 2025 Q4 | 984.5M | 307.8M | 275.7M |
| 2025 Q3 | 957.3M | 324.9M | 100.8M |
| 2025 Q2 | 768.6M | 248.2M | 252.2M |
| 2025 Q1 | 719.4M | 104.6M | 67.6M |
| 2024 Q4 | 660.5M | 412.5M | 68.9M |
| 2024 Q3 | 609.5M | -10.8M | -121.5M |
| 2024 Q2 | 475.9M | 1.2B | 989.2M |
| Period | P/E (TTM) | TTM Net Income | E/P Quarterly | E/P Annual (TTM) |
|---|---|---|---|---|
| 2026 Q1 | 12.3 | 701.5M TRY | 0.0085 | 0.0815 |
| 2025 Q4 | 11.7 | 696.3M TRY | 0.0337 | 0.0851 |
| 2025 Q3 | 18.8 | 489.5M TRY | 0.0110 | 0.0533 |
| 2025 Q2 | 29.8 | 267.2M TRY | 0.0317 | 0.0336 |
| 2025 Q1 | 8.0 | 1.0B TRY | 0.0084 | 0.1248 |
| 2024 Q4 | 7.3 | 1.0B TRY | 0.0093 | 0.1365 |
| 2024 Q3 | 3.9 | 1.8B TRY | -0.0176 | 0.2596 |
| 2024 Q2 | 3.9 | 2.0B TRY | 0.1309 | 0.2585 |
| Period | Net Margin | Gross Margin | ROE | ROA | Debt/Equity | Rev. Growth (YoY) |
|---|---|---|---|---|---|---|
| 2026 Q1 | 7.5% | 33.8% | — | 2.6% | — | +34.8% |
| 2025 Q4 | 28% | 39% | 13.8% | 11.5% | 0.02 | +49% |
| 2025 Q3 | 10.5% | 42.9% | 5.4% | 4.4% | 0.03 | +57.1% |
| 2025 Q2 | 32.8% | 45.7% | 14.9% | 12% | 0.02 | +61.5% |
| 2025 Q1 | 9.4% | 36.1% | 4.4% | 3.5% | 0.06 | +62.7% |
| 2024 Q4 | 10.4% | 36.3% | 5% | 3.9% | 0.06 | +7.7% |
| 2024 Q3 | -19.9% | 35% | -9.5% | -7.2% | 0.05 | +101.9% |
| 2024 Q2 | 207.8% | 34.2% | 80.6% | 61.9% | 0.07 | +124.3% |
| Period | P/B |
|---|---|
| 2026 Q1 | 0.97 |
| 2025 Q4 | 1.02 |
| 2025 Q3 | 1.24 |
| 2025 Q2 | 1.18 |
| 2025 Q1 | 1.32 |
| 2024 Q4 | 1.35 |
| 2024 Q3 | 1.35 |
| 2024 Q2 | 1.54 |
What is the TNZTP stock price?
The current price of TNZTP is 23.68 TRY. (2026-07-16)
What is the TNZTP E/P ratio?
The annual (TTM) E/P ratio of TNZTP is 0.0815. Market cap: 8.6B TRY.
What sector is TNZTP in?
TNZTP (TAPDİ OKSİJEN ÖZEL SAĞLIK VE EĞİTİM HİZMETLERİ SANAYİ TİCARET A.Ş.) operates in the Sağlık sector.
What is the TNZTP P/B ratio?
The P/B (Price-to-Book) ratio of TNZTP is 0.97.
TNZTP Stock Analysis — Borsa Istanbul
This page provides a comprehensive analysis of TNZTP (TAPDİ OKSİJEN ÖZEL SAĞLIK VE EĞİTİM HİZMETLERİ SANAYİ TİCARET A.Ş.), a company listed on Borsa Istanbul in the Sağlık sector. The current share price, daily percentage change, and trading volume are updated at the end of each trading session using official BIST data.
Momentum and Technical Indicators
Short-term and medium-term momentum indicators for TNZTP are calculated using 21-day and 63-day return windows. The 21-day Sortino ratio measures risk-adjusted performance by penalizing only downside volatility, providing a cleaner signal than standard deviation-based metrics. Annualized volatility and 252-day (one-year) momentum are also displayed to help investors assess both trend strength and risk characteristics of TNZTP relative to its sector peers.
Fundamental Metrics
Key valuation ratios include the Earnings-to-Price (E/P) ratio calculated on both quarterly and trailing twelve-month (TTM) bases, the Price-to-Book (P/B) ratio derived from the most recent balance sheet equity, and market capitalization. Financial health indicators such as ROE (Return on Equity), ROA (Return on Assets), net profit margin, gross margin, and debt-to-equity ratio are sourced from the latest disclosed quarterly financial statements filed with KAP (Public Disclosure Platform).
Sector Comparison
TNZTP is compared against other stocks in the Sağlık sector across momentum, valuation, and profitability dimensions. The sector comparison table ranks TNZTP against its peers using percentile scores, making it easy to identify whether the stock is relatively cheap (high E/P), growing faster (high momentum), or more profitable (high ROE) compared to the sector median. All data is refreshed daily and financial ratios are updated each quarter after earnings disclosures.